NEW YORK (GenomeWeb News) – Horizon Discovery said today it has inked a worldwide distribution deal covering Haplogen's haploid cellular models.

Under the terms of the deal, effective immediately, customers will be able to purchase directly from Horizon, Haplogen's Haploid Gene Trap Mutant Collection of isogenic human cell lines deficient for the expression of single genes. Horizon said the deal is its first covering the distribution of another company's products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.